GHO Capital Acquires Sterling Pharma Solutions

March 1, 2019

GHO Capital, a European specialist investor in healthcare, announced its acquisition of Sterling Pharma Solutions, which specializes in complex and difficult-to-manufacture APIs.

In a Feb. 28, 2019 press release, GHO Capital, a European specialist investor in healthcare, announced its acquisition of Sterling Pharma Solutions, which specializes in complex and difficult-to-manufacture APIs.

Kevin Cook, CEO of Sterling Pharma Solutions, commented, “We are delighted to partner with GHO Capital, whose expertise in the pharmaceuticals space and track record of supporting companies expand internationally will be invaluable in facilitating the next stage of our growth in Europe and in the United States.”

“Sterling provides a compelling opportunity to partner with a management team to support the global demand for complex chemistry in pharmaceuticals,” added Alan MacKay, partner at GHO Capital. “Sterling is today a leader in Europe from its United Kingdom operations and the plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.”

Sterling is headquartered in Newcastle-upon-Tyne, UK, and offers specialist services in API development and GMP manufacturing in order to support customers throughout the full product lifecycle.

Source: GHO Capital